ACLX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Gilead Sciences completed the acquisition of Arcellx ahead of the potential commercial launch of anito-celApr 28, 2026
- Arcellx announces new positive data for its iMMagine-1 study in patients with relapsed and/or refractory multiple myeloma.May 14, 2025
- Arcellx announces new positive data for its iMMagine-1 study in patients with relapsed and/or refractory multiple myeloma.May 14, 2025